The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Liam Schofield - Morgans Financial Limited, Research Division - Analyst
: Can you just -- Ross, just touch on that sort of nurses onshoring numbers? I think in the presentation, you commented on it. Can you talk about
sort of basal numbers or nurse numbers where they sort of came from at the end of FY '22, where you ended up and maybe where you think they
can get to in '24?
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: Well done on the cash collections. I'm just curious how we should think about that going forward. Do we expect some sort of reversion of that in
'24? Or is the message that you've sort of rebased your debtor days. Can you just clarify that, please?
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: Yes. Okay. No, that's fine. If I could just sneak in a second question. Just wondering, it's probably in there somewhere, but I found it. Significant
items in the result. Could you just outline what's in that and the quantum of?
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: Just after significant items sort of below the line, it looks like your normalized NPAT is about AUD 28 million and reported NPAT is about AUD 20
million, I think.
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: So what's in that significant -- the difference in there? Is that -- if I could ask about it?
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: Yes, if you could, yes.
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: Right. Okay. Sorry, Megan, you cut out at the crucial time. The strategic review number was how much?
Question: Ken Wagner - Petra Capital Pty Limited, Research Division - Analyst
: Just under AUD 1 million. Okay. And the FIP integration costs?
Question: Liam Schofield - Morgans Financial Limited, Research Division - Analyst
: Sorry, was that one question at a time. Isn't it, Ross? Just very quickly on those underlying changes, the share-based payments. They increased from
AUD 3.3 million to AUD 5.3 million. Is there anything specifically driving that? And what does that look like going out 1, 2 more years?
Question: Liam Schofield - Morgans Financial Limited, Research Division - Analyst
: Got you. So just to clarify, you saying keep it constant as a proportion or keep it constant in total dollars?
|